Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2018
At a glance
- Drugs INO 8000 (Primary) ; INO 9012 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics
- 04 Apr 2018 Status changed from recruiting to suspended as Scheduled interim monitoring.
- 10 Jun 2017 Biomarkers information updated
- 15 Aug 2016 Status changed from not yet recruiting to recruiting.